Annual report pursuant to Section 13 and 15(d)

Debentures (Details Narrative)

Debentures (Details Narrative) - USD ($)												1 Months Ended	12 Months Ended		21 Months Ended
Debentures (Details Narrative) - USD ($)	Mar. 27, 2019	Nov. 08, 2018	Sep. 06, 2018	Aug. 02, 2018	Jul. 16, 2018	Feb. 08, 2018	Sep. 19, 2017	Jul. 17, 2017	Mar. 21, 2017	Feb. 02, 2017	Mar. 31, 2016	Jun. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Jun. 28, 2018	May 21, 2018	May 14, 2018	Mar. 05, 2018	Oct. 31, 2017	Jun. 22, 2017	Jun. 02, 2017	Nov. 03, 2016
Outstanding debentures													$ 12,776,316	$ 5,367,715	$ 12,776,316
Debt due description													Due in 2019
Debt instrument face amount																							$ 341,612
Proceeds from debt													$ 9,000,000	15,742,500
Repayment of debt											$ 500,000
Interest expenses														8,649,232
Amortization of debt discount													$ 17,558,008	10,412,324
Stock converted into debt, value													20,000,000
Unamortized Discount													$ 7,284,194		7,284,194
Issuance Agreements [Member]
Debt instrument face amount		$ 4,300,000	$ 4,300,000	$ 4,300,000	$ 4,300,000
Debt instrument maturity date		Sep. 19, 2019	Sep. 19, 2019	Sep. 19, 2019	Sep. 19, 2019
Proceeds from offerings		$ 3,500,000	$ 3,500,000	$ 3,500,000	$ 3,500,000
TCA Debenture [Member]
Debt instrument maturity date									Jun. 27, 2017
Repayment of debt									$ 750,000
March Debentures [Member]
Debt instrument face amount									$ 1,984,000
Debt instrument maturity date									Mar. 21, 2019
September Debenture [Member]
Principal amount of debt converted into shares					1,741,580
Debentures and Warrants [Member]
Proceeds from debt													24,700,000	24,700,000
Non-cash interest and amortization of debt discount expense													17,600,000	$ 19,000,000
Unamortized Discount													6,200,000		6,200,000
February 2017 Offering [Member]
Debt instrument face amount										$ 1,600,000
Warrants to purchase common stock										13
Exercise price of warrants										$ 19,350
Warrant purchase price										$ 1,500,000
Principal amount of debt converted into shares									$ 2,500,000
March 2017 Offerings [Member]
Debt instrument face amount									$ 10,850,000
Debt instrument maturity date									Mar. 21, 2019
Proceeds from debt									$ 8,400,000
Convertible debt									2,500,000
Interest expenses									400,000
Stock converted into debt									$ 2,700,000
Debt original issue discount, percentage									24.00%
March 2017 Offerings [Member] \| Series H Convertible Preferred Stock [Member]
Stock of convertible preferred stock									$ 2,200,000
March 2017 Offerings [Member] \| March Warrants [Member]
Debt instrument original amount													41,300,000
March 2017 Offerings [Member] \| TCA Debenture [Member]
Repayment of debt									750,000
March 2017 Offerings [Member] \| March Debentures [Member]
Outstanding debentures													$ 2,000,000		2,000,000
Debt instrument face amount																				$ 16,000,000
Stock converted into debt															$ 14,000,000
Debt original issue discount, percentage													100.00%		100.00%
Warrants exercisable													47,300,000,000		47,300,000,000
Debenture description													The March Debentures are convertible into shares of the Company's common stock, at a conversion price which has been adjusted pursuant to the terms of the March Debentures to $.00102 per share as of December 31, 2018, due to prices at which the Company has subsequently issued shares of common stock. The Convertible Debentures began to amortize monthly commencing on the 90th day following the closing date. The Exchange Debentures began to amortize monthly on the closing date. On each monthly amortization date, the Company may elect to repay 5% of the original principal amount of the March Debentures in cash or, in lieu thereof, the conversion price of such debentures will thereafter be 85% of the volume weighted average price at the time of conversion.
Stock converted into debt, value															4,258,172
Debt instrument original amount													$ 15,300,000
Non-cash interest and amortization of debt discount expense													$ 43,700,000
March 2017 Offerings [Member] \| March Debentures [Member] \| Series A Warrant [Member]
Exercise price of warrants													$ .00102		$ .00102
Warrants exercisable													17,900,000,000		17,900,000,000
Warrant term													5 years		5 years
March 2017 Offerings [Member] \| March Debentures [Member] \| Series B Warrant [Member]
Exercise price of warrants													$ .00102		$ .00102
Interest expenses													$ 6,400,000
Warrants exercisable													11,300,000,000		11,300,000,000
Warrant term													18 months		18 months
Amortization of debt discount													$ 8,600,000
Debenture description													The Company extended the exercise period twice, once to March 21, 2019 and the second time to June 21, 2019
March 2017 Offerings [Member] \| March Debentures [Member] \| Series B Warrant [Member] \| Subsequent Event [Member]
Warrant description	The expiration date of the Series B Warrants was extended 90 days to September 21, 2019 and again on May 10, 2019 to March, 31, 2022.
March 2017 Offerings [Member] \| March Debentures [Member] \| Series C Warrant [Member]
Exercise price of warrants													$ .00102		$ .00102
Warrants exercisable													18,200,000,000		18,200,000,000
Warrant term													5 years		5 years
March 2017 Offerings [Member] \| Mr Diamantis [Member]
Repayment of debt									$ 3,800,000
June 2017 Offerings [Member] \| June Warrants [Member]
Warrants to purchase common stock																					133	67
Exercise price of warrants																					$ 2,850	$ 2,925
June 2017 Offerings [Member] \| June Debentures [Member]
Warrants to purchase common stock												200
Amortization of debt discount													$ 107,700
June 2017 Offerings [Member] \| Accredited Investor [Member] \| June Warrants [Member]
Warrant purchase price												$ 1,902,700
Proceeds from issuance warrants												$ 1,500,000
July 2017 Offerings [Member]
Debt instrument face amount								$ 4,136,862
Warrants to purchase common stock								283
Exercise price of warrants													$ 2,812.50		$ 2,812.50
Principal amount of debt converted into shares								$ 1,902,700
Debt instrument maturity date								Oct. 17, 2017
Warrant consideration in cash								$ 2,000,000
July 2017 Offerings [Member] \| July Debentures [Member]
Principal amount of debt converted into shares							$ 6,400,000
September 2017 Offerings [Member]
Debt instrument face amount							2,604,000
Principal amount of debt converted into shares							$ 4,136,862
Debt instrument maturity date							Sep. 19, 2019
Interest expenses													$ 1,000,000
Debt original issue discount, percentage													24.00%		24.00%
Amortization of debt discount													$ 100,000
Debenture description													On each monthly amortization date, the Company may elect to repay 5% of the original principal amount of September Debentures in cash or, in lieu thereof, the conversion price of such September Debentures shall thereafter be 85% of the volume weighted average price at the time of conversion, but not less than the floor of $390.00 per share.
Proceeds from offerings							$ 2,100,000
Conversion price per share													$ 390.00		$ 390.00
September 2017 Offerings [Member] \| September Warrants [Member]
Exercise price of warrants													$ 390.00		$ 390.00
September 2017 Offerings [Member] \| Series A Warrant [Member]
Warrants to purchase common stock							69,355
Warrants exercisable													23,118		23,118
Warrant term													5 years		5 years
September 2017 Offerings [Member] \| Series B Warrant [Member]
Warrants to purchase common stock							69,355
Warrants exercisable													23,119		23,119
Warrant term													18 months		18 months
September 2017 Offerings [Member] \| Series B Warrant [Member] \| Subsequent Event [Member]
Warrant description	The expiration date of these Series B Warrants was extended 90 days to September 21, 2019 and again on May 10, 2019 the expiration date was extended to March, 31, 2022.
September 2017 Offerings [Member] \| Series C Warrant [Member]
Warrants to purchase common stock							69,355
Warrants exercisable													23,118		23,118
Warrant term													5 years		5 years
September 2017 Offerings [Member] \| September Debenture [Member]
Principal amount of debt converted into shares							$ 6,412,136
Stock converted into debt					$ 1,741,580	$ 1,384,556
Stock converted into debt, value					2,176.9	1,730.1
Loss on exchange of stock					$ 819,561	$ 651,562
2018 Offerings [Member]
Debt instrument face amount																$ 6,810,000	$ 6,810,000	$ 6,810,000	$ 6,810,000
Debt instrument maturity date													Sep. 19, 2019
Amortization of debt discount													$ 1,310,000
Proceeds from offerings													$ 5,500,000
Conversion price per share													$ .052		$ .052